Skip to main content
Start Project

Sample Sprint deliverable

Example Market Entry Sprint output

This is the structure of a GHMAP Market Entry Sprint package: source status, evidence gaps, country questions, and next actions. Example only — not a real regulatory or reimbursement conclusion.

Sample Sprint deliverable

Example only — source status, evidence gaps, and next actions without regulatory conclusions.

Demo brief for product illustration only. Source verification and professional review required before business use.

A paid Market Entry Sprint delivers a reviewed package for your product and target country in 10 business days, plus a 60-minute review call. See pricing.

Country comparison dashboard

Country questions stay separated from conclusions.

This demo shows the type of country-by-country question structure GHMAP can organize. It does not provide actual regulatory, reimbursement, payer, procurement, or pricing conclusions.

CountryRegulatory questionReimbursement questionPayer/procurement questionEvidence gapRequired source typeStatusNext action
GermanyConfirm applicable pathway with official source.Identify payer or reimbursement route requiring verification.Map public/private payer or procurement process.Local evidence expectations to verify.Official regulator / payer / HTA / procurement source required.To verifyAttach source and assign reviewer.
UAEConfirm applicable pathway with official source.Identify payer or reimbursement route requiring verification.Map public/private payer or procurement process.Local evidence expectations to verify.Official regulator / payer / HTA / procurement source required.To verifyAttach source and assign reviewer.
Saudi ArabiaConfirm applicable pathway with official source.Identify payer or reimbursement route requiring verification.Map public/private payer or procurement process.Local evidence expectations to verify.Official regulator / payer / HTA / procurement source required.To verifyAttach source and assign reviewer.

Evidence readiness matrix

Evidence gaps become reviewable work items.

The matrix keeps each evidence category tied to a country, source requirement, owner role, and current status.

Evidence areaGermanyUAESaudi ArabiaRequired sourceOwner roleStatus
Product classificationSource requiredTo verifySource requiredOfficial regulator sourceRegulatory reviewerIncomplete
Clinical evidenceTo verifySource requiredTo verifyApproved evidence packageClinical evidence reviewerProfessional review required
Economic evidenceSource requiredTo verifySource requiredEconomic evidence sourceHealth economics reviewerIncomplete
Local payer expectationsTo verifyTo verifySource requiredPayer / reimbursement sourceReimbursement reviewerSource required
Procurement/tender evidenceDemo onlySource requiredTo verifyProcurement / tender sourceProcurement reviewerSource required
Competitor contextExample onlyExample onlyExample onlyVerified market context sourceMarket-access analystDemo only
Local expert reviewProfessional review requiredProfessional review requiredProfessional review requiredReviewer noteLocal expert reviewerProfessional review required

Review workflow timeline

A brief stays locked until source and professional review work is complete.

Most stages in this public demo remain marked demo, incomplete, or locked so the output does not imply reliance-ready content.

  1. Draft created

    Demo only
  2. Source requirements identified

    Example only
  3. Evidence attached

    Incomplete
  4. source-checked output

    Demo preview
  5. Reviewer assigned

    To verify
  6. Professional review completed

    Not completed
  7. Export approved

    Locked

draft output format

Source-aware preview

Summary

GHMAP would summarize attached, approved sources here.

Assumptions

Assumptions remain unverified until sources are attached.

Missing evidence

Official sources required before business reliance.

Source list

No verified source attached in this demo.

Confidence

Demo only / insufficient for reliance.

Human review required

Professional review required.

Recommended next actions

Attach sources, assign reviewer, confirm country-specific pathway.

Export preview

Export available after source review.

Export actions are disabled in this public demo. The brief remains locked until source review and professional review are complete.

Source governance

Source status, evidence gaps, review needs, and next actions stay visible before export.

Request the real deliverable

Start a Market Entry Sprint for your product and country

$2,500 · 10 business days · pathway outline, reimbursement and evidence flags, gaps, next actions, and a review call.

Example output shown. A real Market Entry Sprint is scoped for one product and one country.